Back
Eli Lilly & Co. Vs. Novo Nordisk A/S Sector Stock Comparison
Buy
84
LLY
Eli Lilly & Co.
Last Price:
$1,076.82
Seasonality Move:
2.87%
Sell
37
NVO
Novo Nordisk A/S
Last Price:
$52.50
Seasonality Move:
3.96%
Buy
84
Eli Lilly & Co. (LLY)
is a Buy
Is Eli Lilly & Co. a Buy, Sell or Hold?
-
The current Eli Lilly & Co. [LLY] share price is $1,076.98. The Score for LLY is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
-
LLY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
37
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $52.56. The Score for NVO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LLY Stock Price Chart
What is Eli Lilly & Co.'s stock price today?
-
The Eli Lilly & Co. share price today is $1,076.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $52.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight selling pressure.
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 24.52 | Buy |
| Relative Strength Index (14 RSI): | 64.19 | Buy |
| Chaikin Money Flow: | -320965 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1015.55 - 1080.21) | Buy |
| Bollinger Bands (100): | (719.2 - 996.84) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 62.78 | Buy |
| Chaikin Money Flow: | -6038682 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.84 - 50.06) | Buy |
| Bollinger Bands (100): | (48.26 - 56.98) | Sell |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1063.96 | Buy |
| 20-day SMA: | 1043.21 | Buy |
| 50-day SMA: | 970.89 | Buy |
| 200-day SMA: | 821.52 | Buy |
| 8-day EMA: | 1061.64 | Buy |
| 20-day EMA: | 1041.42 | Buy |
| 50-day EMA: | 980.25 | Buy |
| 200-day EMA: | 858.86 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.38 | Buy |
| 20-day SMA: | 48.75 | Buy |
| 50-day SMA: | 49.62 | Buy |
| 200-day SMA: | 60.42 | Sell |
| 8-day EMA: | 49.85 | Buy |
| 20-day EMA: | 49.14 | Buy |
| 50-day EMA: | 50.29 | Buy |
| 200-day EMA: | 62.73 | Sell |
Eli Lilly & Co. Earnings Growth & LLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.85 per share, and an increase next year of $8.98 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and a decrease next year of $0.17 per share.
Eli Lilly & Co. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||